Chronic cough, defined as a cough lasting more than eight weeks, presents a common yet complex challenge in clinical practice. Despite its prevalence, the etiology often remains elusive, leading to diagnostic uncertainty and therapeutic dilemmas. This article aims to illuminate a comprehensive approach to diagnosing and managing chronic cough.
Chronic cough can be attributed to a myriad of causes, from common conditions like asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS) to less prevalent etiologies like lung cancer. A detailed patient history coupled with targeted investigations can help pinpoint the underlying cause.
The diagnostic approach should be systematic and patient-centric. Initial evaluation should include a thorough history and physical examination, focusing on identifying common causes and risk factors. If the cause is not readily apparent, further investigations such as imaging, spirometry, and bronchoscopy may be warranted. Empirical therapy can be considered in certain cases, but should not delay definitive diagnosis.
Management should be tailored based on the identified etiology. For instance, asthma-related cough may respond well to inhaled corticosteroids, while GERD-associated cough may require proton pump inhibitors. Non-pharmacological interventions, such as lifestyle modifications and physiotherapy, can also play a crucial role. Refractory cases may necessitate referral to a specialist.
Research is ongoing to develop novel diagnostic tools and therapeutic options for chronic cough. Emerging modalities like cough reflex testing and potential new drugs targeting neural pathways are promising. More studies are needed to validate their efficacy and safety.
Chronic cough is a multifaceted problem requiring a comprehensive and individualized approach. By maintaining a high index of suspicion, employing a systematic diagnostic strategy, and tailoring management based on etiology, clinicians can effectively diagnose and manage this common but often perplexing condition.
1.
What is a "cancer vaccine" and is it the same as a COVID vaccine?
2.
Advances in "next generation" photoactive cancer therapy
3.
Nonmelanoma skin cancer has been linked to occupational exposure to solar UVR.
4.
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis
5.
FDA Approves New Bladder Cancer First-Line Standard of Care.
1.
Hemophilia B and Gene Therapy: A New Chapter with Etranacogene Dezaparvovec
2.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
3.
The latest Hematocrit: An Overview of Red Blood Cell Health
4.
Contemporary Trends in Oncology and Patient Outcomes
5.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
5.
Efficient Management of First line ALK-rearranged NSCLC - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation